Items where Author is "Croft, SL"

Up a level
Export as [feed] Atom [feed] RSS
Group by: Year | Item Type | Full Text
Jump to: 2018 | 2017 | 2016 | 2015 | 2014 | 2011 | 2006
Number of items: 34.


Burza, S; Croft, SL; Boelaert, M; (2018) Leishmaniasis. Elsevier. DOI: Full text not available from this repository.

Van Bocxlaer, K; Gaukel, E; Hauser, D; Park, SH; Schock, S; Yardley, V; Randolph, R; Plattner, JJ; Merchant, T; Croft, SL; +2 more... Jacobs, RT; Wring, SA; (2018) Topical treatment for cutaneous leishmaniasis - dermato-pharmacokinetic led optimisation of benzoxaboroles. Antimicrobial agents and chemotherapy. ISSN 0066-4804 DOI:

Wijnant, GJ; Van Bocxlaer, K; Yardley, V; Harris, A; Alavijeh, M; Silva-Pedrosa, R; Antunes, S; Mauricio, I; Murdan, S; Croft, SL; (2018) Comparative efficacy, toxicity and biodistribution of the liposomal amphotericin B formulations Fungisome® and AmBisome® in murine cutaneous leishmaniasis. International journal for parasitology Drugs and drug resistance, 8 (2). pp. 223-228. ISSN 2211-3207 DOI:


Baker, DA; Stewart, LB; Large, JM; Bowyer, PW; Ansell, KH; Jiménez-Díaz, MB; El Bakkouri, M; Birchall, K; Dechering, KJ; Bouloc, NS; +19 more... Coombs, PJ; Whalley, D; Harding, DJ; Smiljanic-Hurley, E; Wheldon, MC; Walker, EM; Dessens, JT; Lafuente, MJ; Sanz, LM; Gamo, FJ; Ferrer, SB; Hui, R; Bousema, T; Angulo-Barturén, I; Merritt, AT; Croft, SL; Gutteridge, WE; Kettleborough, CA; Osborne, SA; (2017) A potent series targeting the malarial cGMP-dependent protein kinase clears infection and blocks transmission. Nature communications, 8 (1). p. 430. ISSN 2041-1723 DOI:
[img] [img]

Basilico, N; Parapini, S; Sparatore, A; Romeo, S; Misiano, P; Vivas, L; Yardley, V; Croft, SL; Habluetzel, A; Lucantoni, L; +8 more... Renia, L; Russell, B; Suwanarusk, R; Nosten, F; Dondio, G; Bigogno, C; Jabes, D; Taramelli, D; (2017) In Vivo and In Vitro Activities and ADME-Tox Profile of a Quinolizidine-Modified 4-Aminoquinoline: A Potent Anti-P. falciparum and Anti-P. vivax Blood-Stage Antimalarial. Molecules (Basel, Switzerland), 22 (12). ISSN 1420-3049 DOI:

Burrell-Saward, H; Harris, AJ; de LaFlor, R; Sallam, H; Alavijeh, MS; Ward, TH; Croft, SL; (2017) Dose-dependent effect and pharmacokinetics of fexinidazole and its metabolites in a mouse model of human african trypanosomiasis. International journal of antimicrobial agents, 50 (2). pp. 203-209. ISSN 0924-8579 DOI:


Cameron, MM; Acosta-Serrano, A; Bern, C; Boelaert, M; den Boer, M; Burza, S; Chapman, LA; Chaskopoulou, A; Coleman, M; Courtenay, O; +21 more... Croft, S; Das, P; Dilger, E; Foster, G; Garlapati, R; Haines, L; Harris, A; Hemingway, J; Hollingsworth, TD; Jervis, S; Medley, G; Miles, M; Paine, M; Picado, A; Poché, R; Ready, P; Rogers, M; Rowland, M; Sundar, S; de Vlas, SJ; Weetman, D; (2016) Understanding the transmission dynamics of Leishmania donovani to provide robust evidence for interventions to eliminate visceral leishmaniasis in Bihar, India. Parasites & vectors, 9 (1). p. 25. ISSN 1756-3305 DOI:

Hendrickx, S; Guerin, PJ; Caljon, G; Croft, SL; Maes, L; (2016) Evaluating drug resistance in visceral leishmaniasis: the challenges. Parasitology, 145 (4). pp. 453-463. ISSN 0031-1820 DOI:

Tegazzini, D; Díaz, R; Aguilar, F; Peña, I; Presa, JL; Yardley, V; Martin, JJ; Coteron, JM; Croft, SL; Cantizani, J; (2016) A replicative in vitro assay for drug discovery against Leishmania donovani. Antimicrobial agents and chemotherapy, 60 (6). pp. 3524-32. ISSN 0066-4804 DOI:

Van Bocxlaer, K; Yardley, V; Murdan, S; Croft, SL; (2016) Drug permeation and barrier damage in Leishmania-infected mouse skin. The Journal of antimicrobial chemotherapy, 71 (6). pp. 1578-85. ISSN 0305-7453 DOI: Full text not available from this repository.

Van Bocxlaer, K; Yardley, V; Murdan, S; Croft, SL; (2016) Topical formulations of miltefosine for cutaneous leishmaniasis in a BALB/c mouse model. The Journal of pharmacy and pharmacology, 68 (7). pp. 862-72. ISSN 0022-3573 DOI:

Xu, J; Bergquist, R; Qian, YJ; Wang, Q; Yu, Q; Peeling, R; Croft, S; Guo, JG; Zhou, XN; (2016) China-Africa and China-Asia Collaboration on Schistosomiasis Control: A SWOT Analysis. Adv Parasitol, 92. pp. 435-66. ISSN 2163-6079 DOI: Full text not available from this repository.


Croft, SL; Buffett, P; (2015) Leishmaniasis. In: Goldman, L; Schafer, AI, (eds.) Goldman’s Cecil Medicine, 25th ed. Elsevier-Saunders, pp. 2120-2025. Full text not available from this repository.

Croft, SL; Ward, S; (2015) The Nobel Prize in Medicine 2015: Two drugs that changed global health. Science translational medicine, 7 (316). 316ed14. ISSN 1946-6234 DOI: Full text not available from this repository.

Kaur, H; Seifert, K; Hawkes, GE; Coumbarides, GS; Alvar, J; Croft, SL; (2015) Chemical and Bioassay Techniques to Authenticate Quality of the Anti-Leishmanial Drug Miltefosine. The American journal of tropical medicine and hygiene, 92 (6 Supp). pp. 31-8. ISSN 0002-9637 DOI:

Riede, O; Seifert, K; Oswald, D; Endmann, A; Hock, C; Winkler, A; Salguero, FJ; Schroff, M; Croft, SL; Juhls, C; (2015) Preclinical safety and tolerability of a repeatedly administered human leishmaniasis DNA vaccine. Gene therapy, 22 (8). pp. 628-35. ISSN 0969-7128 DOI:

Seifert, K; Juhls, C; Salguero, FJ; Croft, SL; (2015) Sequential chemo-immunotherapy of experimental visceral leishmaniasis using single low dose liposomal amphotericin B and a novel DNA vaccine candidate. Antimicrobial agents and chemotherapy, 59 (9). pp. 5819-23. ISSN 0066-4804 DOI: Full text not available from this repository.


Barrett, MP; Croft, SL; (2014) Emerging paradigms in anti-infective drug design. Parasitology, 141 (1). pp. 1-7. ISSN 0031-1820 DOI:

Das, S; Freier, A; Boussoffara, T; Das, S; Oswald, D; Losch, FO; Selka, M; Sacerdoti-Sierra, N; Schönian, G; Wiesmüller, KH; +10 more... Seifert, K; Schroff, M; Juhls, C; Jaffe, CL; Roy, S; Das, P; Louzir, H; Croft, SL; Modabber, F; Walden, P; (2014) Modular multiantigen T cell epitope-enriched DNA vaccine against human leishmaniasis. Science translational medicine, 6 (234). 234ra56. ISSN 1946-6234 DOI: Full text not available from this repository.

Ganguly, NK; Croft, S; Singh, L; Sinha, S; Balganesh, T; (2014) Biomedicine and biotechnology: public health impact. BioMed research international, 2014. p. 524785. ISSN 2314-6133 DOI:

Lamour, SD; Veselkov, KA; Posma, JM; Giraud, E; Rogers, ME; Croft, S; Marchesi, JR; Holmes, E; Seifert, K; Saric, J; (2014) Metabolic, Immune, and Gut Microbial Signals Mount a Systems Response to Leishmania major Infection. Journal of proteome research, 14 (1). pp. 318-329. ISSN 1535-3893 DOI: Full text not available from this repository.

Sanderson, L; Yardley, V; Croft, SL; (2014) Activity of anti-cancer protein kinase inhibitors against Leishmania spp. The Journal of antimicrobial chemotherapy. ISSN 0305-7453 DOI: Full text not available from this repository.


Croft, SL; Olliaro, P; (2011) Leishmaniasis chemotherapy-challenges and opportunities. Clinical microbiology and infection, 17 (10). pp. 1478-83. ISSN 1198-743X DOI: Full text not available from this repository.


Laurent, T; Rijal, S; Yardley, V; Croft, S; De Doncker, S; Decuypere, S; Khanal, B; Singh, R; Schönian, G; Kuhls, K; +2 more... Chappuis, F; Dujardin, JC; (2006) Epidemiological dynamics of antimonial resistance in Leishmania donovani: Genotyping reveals a polyclonal population structure among naturally-resistant clinical isolates from Nepal. Infection, genetics and evolution, 7 (2). pp. 206-12. ISSN 1567-1348 DOI: Full text not available from this repository.

Perez-Victoria, FJ; Sanchez-Canete, MP; Seifert, K; Croft, SL; Sundar, S; Castanys, S; Gamarro, F; (2006) Mechanisms of experimental resistance of Leishmania to miltefosine: Implications for clinical use. Drug resistance updates, 9 (1-2). pp. 26-39. ISSN 1368-7646 DOI: Full text not available from this repository.

This list was generated on Tue Nov 27 05:46:28 2018 GMT.